Reply: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis

Survival differences favouring antifibrotic therapy from INSIGHTS-IPF registry data are not compromised by immortal and lead time biaseshttps://bit.ly/3tDpk1S